A new identity
IBA Molecular and Mallinckrodt Nuclear Medicine LLC proudly unite to become one singular global organisation: Curium.
Our new name is inspired by the pioneering spirit and radiation research performed by Marie and Pierre Curie. It is also a reiteration of our focus on nuclear medicine.
We aim to be a catalyst of Nuclear Medicine industry growth. This means continuously channelling resources and investment into our industry to support its growing role in global healthcare.
Visually, the Curium identity conveys a sense of continuity and advancement along the patient care continuum. Our brand tagline, Life Forward, encapsulates our commitment to customers and the industry we serve.
Together, they demonstrate our dedication to enhancing the quality of health outcomes through patient care, life-saving diagnostics and treatment.